0.782
前日終値:
$0.72
開ける:
$0.7403
24時間の取引高:
134.39K
Relative Volume:
1.02
時価総額:
$97.15M
収益:
-
当期純損益:
$-70.78M
株価収益率:
-1.3964
EPS:
-0.56
ネットキャッシュフロー:
$-61.27M
1週間 パフォーマンス:
+1.55%
1か月 パフォーマンス:
-21.01%
6か月 パフォーマンス:
-71.87%
1年 パフォーマンス:
-67.69%
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
名前
Nautilus Biotechnology Inc
セクター
電話
206-333-2001
住所
2701 EASTLAKE AVE EAST, SEATTLE
NAUT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
NAUT
Nautilus Biotechnology Inc
|
0.782 | 97.15M | 0 | -70.78M | -61.27M | -0.56 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
490.47 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
585.49 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
599.87 | 36.96B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
236.75 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
252.77 | 25.74B | 3.81B | -644.79M | -669.77M | -6.24 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-05 | ダウングレード | Goldman | Neutral → Sell |
2024-06-27 | 開始されました | Guggenheim | Buy |
2024-06-03 | 再開されました | Jefferies | Hold |
2022-01-06 | 開始されました | Morgan Stanley | Equal-Weight |
2021-11-02 | 開始されました | Cowen | Outperform |
2021-08-04 | 開始されました | Goldman | Neutral |
2021-07-13 | 開始されました | Jefferies | Buy |
すべてを表示
Nautilus Biotechnology Inc (NAUT) 最新ニュース
Short Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Increases By 20.5% - Defense World
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 - The Manila Times
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - MarketScreener
NAUT Stock Plummets to 52-Week Low at $0.82 Amid Market Turbulence By Investing.com - Investing.com South Africa
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Stock Position Decreased by Charles Schwab Investment Management Inc. - Defense World
NAUT Stock Plummets to 52-Week Low at $0.82 Amid Market Turbulence - Investing.com
Virtu Financial LLC Takes $28,000 Position in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Virtu Financial LLC Takes $30,000 Position in FlexShopper, Inc. (NASDAQ:FPAY) - Defense World
We're Keeping An Eye On Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate - Yahoo Finance
Nautilus Biotechnology: Hold Rating Amid Delayed Launch and Strategic Adjustments - TipRanks
Nautilus Biotechnology’s Earnings Call: Progress Amid Challenges - TipRanks
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2024 Earnings Call Transcript - Insider Monkey
Nautilus Biotechnology lays off 16% of workforce, plans release of commercial platform in 2026 - MSN
Nautilus: Trading Below An Albeit Lower Net Cash Figure (NASDAQ:NAUT) - Seeking Alpha
Guggenheim cuts Nautilus Biotech target to $2.50, keeps buy rating - Investing.com
Guggenheim cuts Nautilus Biotech target to $2.50, keeps buy rating By Investing.com - Investing.com South Africa
Nautilus Biotechnology Reports 2024 Financial Results - TipRanks
Seattle's Nautilus Biotechnology lays off 16% of its staff - The Business Journals
Nautilus Biotechnology Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Nautilus Q4 2024 highlights platform delay - Investing.com
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results - The Manila Times
Nautilus Cuts 16% of Workforce as Biotech Platform Launch Slips to 2026What's Next? - StockTitan
Nautilus Biotechnology Announces Board Changes for 2025 - TipRanks
Nautilus Biotechnology (NAUT) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Blade Air Mobility Leads The Charge Among 3 US Penny Stocks - Simply Wall St
Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference - The Manila Times
Exclusive: Nautilus Biotech Unveils Next-Gen Protein Analysis Breakthrough at Major Healthcare Summit - StockTitan
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Down 68.8% in January - MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 5.9%Time to Sell? - MarketBeat
SG Americas Securities LLC Buys 9,904 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
NAUTNautilus Biotechnology Inc Latest Stock News & Market Updates - StockTitan
Nautilus Bio Q4 Earnings Alert: Protein Analysis Pioneer Reports Feb 27 - StockTitan
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewswire
One Nautilus Biotechnology Insider Raised Their Stake In The Previous Year - Yahoo Canada Finance
Nautilus Biotech announces board member changes By Investing.com - Investing.com Australia
Nautilus Biotech announces board member changes - MSN
Nautilus Biotechnology Announces Board Member Departures - MSN
NAUTILUS BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
Barclays PLC Buys 47,059 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Jeff Bezos Stock Portfolio: Top Investment Picks - CoinCodex
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Down 14.2% in December - MarketBeat
Barclays PLC Has $1.04 Million Holdings in Northfield Bancorp, Inc. (Staten Island, NY) (NASDAQ:NFBK) - Defense World
Jane Street Group LLC Sells 25,020 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
EZCORP, Inc. (NASDAQ:EZPW) Shares Acquired by Barclays PLC - Defense World
Nautilus Biotechnology Inc (NAUT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):